Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020
Revisado por: Cristina Calvo
Grupo de trabajo: Infecciones Respiratorias
Referencia: Walsh PS, Schnadower D, Zhang Y, Ramgopal S, Shah SS, Wilson PM. Association of Early Oseltamivir With Improved Outcomes in Hospitalized Children With Influenza, 2007-2020. JAMA Pediatr. 2022 Nov 1;176(11):e223261. doi: 10.1001/jamapediatrics.2022.3261
Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009
Revisado por: Laura Ferreras-Antolin
Grupo de trabajo: Infección Fúngica Invasiva
Referencia: Lehrnbecher, T., Groll, A.H., Cesaro, S. et al. Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009. Leukemia (2022). https://doi.org/10.1038/s41375-022-01768-x
Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate
Revisado por: Anabel Piqueras Arenas
Grupo de trabajo: Infecciones relacionadas con la asistencia sanitaria
Referencia: Cortés-Penfield N, Ryder JH. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate. Clin Infect Dis. 2022 Sep 3: ciac720.
Estimation of the morbidity and mortality of congenital Chagas disease: A systematic review and meta-analysis
Revisado por: Alicia Hernanz Lobo
Grupo de trabajo: Patología Importada
Referencia: Matthews S, Tannis A, Puchner KP, et al. Estimation of the morbidity and mortality of congenital Chagas disease: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2022 Nov 7;16(11):e0010376. doi: 10.1371/journal.pntd.0010376. PMID: 36342961.
A Tool to Distinguish Viral From Bacterial Pneumonia
Revisado por: Marta Cruz Cañete
Grupo de trabajo: Infecciones Respiratorias
Referencia: Tagarro A, Moraledas C, Dominguez- Rodriguez S, Rodriguez-Dominguez M, Martín M, Fernandez M. Luisa, et al. A Tool to Distinguish Viral From Bacterial Pneumonia. Pediatr Infect Dis J 2022; 41:31-36. DOI 10.1097/INF.0000000000003340
Duration of antibiotic treatment for Gram-negative bacteremia-Systematic review and individual participant data (IPD) meta-analysis
Revisado por: Eneritz Velasco-Arnaiz
Grupo de trabajo: Infecciones relacionadas con la asistencia sanitaria
Referencia: Turjeman A, von Dach E, Molina J, et al. Duration of antibiotic treatment for Gram-negative bacteremia-Systematic review and individual participant data (IPD) meta-analysis. EClinicalMedicine. 2022 Dec 1;55:101750. doi: 10.1016/j.eclinm.2022.101750.
Antibiotic treatment duration for community-acquired pneumonia in outpatient children in high-income countries –A systematic review and meta-analysisis
Revisado por: Carlos Pérez Méndez
Grupo de trabajo: Infecciones Respiratorias
Referencia: Kuitunen I, Jääskeläinen J, Korppi M, Renko M. Antibiotic treatment duration for community-acquired pneumonia in outpatient children in high-income countries –A systematic review and meta-analysisis. Clin Infect Dis. 2022. doi: 10.1093/cid/ciac374.
Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents
Revisado por: Natalia Mendoza Palomar
Grupo de trabajo: Infección Fúngica Invasiva
Referencia: Fisher BT, Boge CLK, Xiao R, et al. Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents. Clin Infect Dis. 2022 Jan 20:ciab928. doi: 10.1093/cid/ciab928.
